Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1366998 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
Novel small molecules were designed to specifically target the ligand-binding pocket of a PDZ domain. Iterative molecular docking and modeling allowed the design of an indole scaffold 10a as a reversible inhibitor of ligand binding. The 10a scaffold inhibited the interaction between MAGI-3 and PTEN and showed cellular activities that are consistent with the inhibition of NHERF-1 function.
Graphical abstractNovel small molecules were designed to specifically target the ligand-binding pocket of a PDZ domain.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Naoaki Fujii, Jose J. Haresco, Kathleen A.P. Novak, Robert M. Gage, Nicoletta Pedemonte, David Stokoe, Irwin D. Kuntz, R. Kiplin Guy,